Received Jun 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | Unknown | IM / LA |
inadvertent administration of the RabAvert to the same anatomical site as the immunoglobulin dose; Case reference number US-BN-2025-001339 is a spontaneous case initially received from a pharmacist via agency (reference number: USBAV25-1883) on 31-Jul-2025 and concerns 27-year-old male patient. The patient's medical history was not provided. The patient's concomitant medications included human immunoglobulin for an unknown indication. On an unspecified date, the patient had skunk bite. On 31-Jul-2025, unknown time after skunk bite, the patient received the first dose of RabAvert (batch number: unknown) at dose of 1.0 mL, intramuscularly to the left deltoid, post exposure to skunk bite. As reported, RabAvert was inadvertently administered to the same anatomical site as the immunoglobulin (also reported as 'Hum Globulin') at unknown dose, intramuscularly to the left deltoid, post exposure to skunk bite (explicitly coded as 'lack of vaccination site rotation'). As reported, no treatment was given due to the event, and no laboratory tests were performed. At the time of initial, report it was unknown if the patient experienced any adverse event due to RabAvert vaccine. No additional information was provided.; Reporter's Comments: A 27-year-old male patient received the first dose of RabAvert intramuscularly to the left deltoid, post exposure to skunk bite. As reported, RabAvert was inadvertently administered to the same anatomical site as the immunoglobulin intramuscularly to the left deltoid, post exposure to skunk bite, which is considered as lack of vaccination site rotation. It was unknown if the patient experienced any adverse event due to RabAvert vaccine. Lack of vaccination site rotation is considered as listed per company convention. The patient's medical history was not provided, and concomitant medications included human immunoglobulin for an unknown indication. Lack of vaccination site rotation is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 27-year-old male patient received the first dose of RabAvert intramuscularly to the left deltoid, post exposure to skunk bite. As reported, RabAvert was inadvertently administered to the same anatomical site as the immunoglobulin intramuscularly to the left deltoid, post exposure to skunk bite, which is considered as lack of vaccination site rotation. It was unknown if the patient experienced any adverse event due to RabAvert vaccine. Lack of vaccination site rotation is considered as listed per company convention. The patient's medical history was not provided, and concomitant medications included human immunoglobulin for an unknown indication. Lack of vaccination site rotation is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None
HUMAN IMMUNOGLOBULIN